[1] Masahiro M，Yasuyoshi K，Eiko K，et al. Targeted disruption of NP95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks[J]. J Biol Chem，2002，277(37)： 34549-34555.

[2] Masahiro M，Akira F，Mituru N，et al. Isolation and characterization of a novel human radiosusceptibility gene， NP95[J]. Radiat Res，2006，166(5)： 723-733.

[3] Bronner C，Achour M，Arima Y，et a1. The UHRF family： oncogenes that are drugable targets for cancer therapy in the near future?[J]. Pharmacol Ther，2007，115(3)： 419-434.

[4] Ian Marc B，Lucia L，Roberto P，et al. NP95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry[J]. J Cell Biol，2002， 157(6)： 909-914.

[5] Masahiko M，Hiroshi W，Takehito S，et al. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci[J]. Exp Cell Res，2001，263(2)： 202-208.

[6] Sharif J，Muto M，Takebayashi S，et al. The SRA protein NP95 mediates epigenetic inheritance by recruiting dnmtl to methylated DNA[J]. Nature，2007，450(7171)： 908-909.

[7] Sharif J，Muto M. Recruitment of Dnmt1 roles of the SRA protein Np95 (UHRF1) and other factors[J]. Prog Mol Biol Transl Sci，2011，101(3)：289-310.

[8] Mousli M，Hopfner R，Abbady AQ，et a1. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells[J]. British J Cancer，2003，89(1)：120-127.

[9] Li XL，Meng QH，Fan SJ. Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to γ-irradiation[J]. Acta Pharmacol Sin，2009， 30(4)：458-466.

[10] Marianne L，Stephanie C，Christian B，et a1. Cell cycle and/or proliferation markers： what is the best method to discriminate cervical high-grade lesions?[J]. Hum Pathol， 2005，36(10)：1101-1107.

[11] Pi JT，Lin Y，Quan Q，et al. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma[J]. Med Oncol，2013， 30(4)：613.

[12] Crnogorac-Jurcevic T，Gangeswaran R，Bhakta V，et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma [J]. Gastroenterology，2005，129(5)：1454-1463.

[13] Unoki M，Daigo Y，Koinuma J，et a1．UHRF1 is a novel diagnostic marker of lung cancer[J]．British Cancer，2010， 103(2)：217-222.

[14] Unoki M，Kelly JD，Neal DE，et a1．UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer[J]．British Cancer，2009，101(1)：98-105.

[15] Hopfner R，Mousli M，Oudet P，et al. Overexpression of ICBP90，a novel CCAAT-binding protein，overcomes cell contact inhibition by forcing topoisomeraseⅡalpha expression[J]. Anti-cancer Res，2002，22(6A)：3165-3170.

[16] Quan ZW，Yang Y，Li JY，et al. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin： cell cycle modulation plus target enzyme up-regulation[J]. Biomed Pharmacother，2010， 64(7)：451-457.

[17] Jenkins Y，Markovtsov V，Lang W，et al. Critical role of the ubiquitin ligase activity of NP95，a nuclear RING finger protein，in tumor cell growth[J]. Mol Biol Cell，2005， 16(12)： 5621-5629.

[18] Daskalos A，Oleksiewicz U，Filia A，et al. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer[J]. Cancer，2011，117(5)：1027-1037.

[19] Arima Y，Hirota T，Bronner C，et al. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition[J]. Genes Cells，2004，9(2)：131-142.

[20] Trotzier MA，Bronner C，Bathami K，et al. Phosphorylation of ICBP90 by protein kinase a enhances topoisomerase Ⅱ alpha expression[J]. Biochem Biophys Commun，2004，19(2)：590-595.

[21] Jeanblanc M，Mousli M，Hopfner R，et al. The retinoblastoma gene and its product are targeted by ICBP90： a key mechanism in the G1/S transition during the cell cycle[J]. Oncogene， 2005，24(49)：7337-7345.

[22] Bianchi C，Zangi R. UHRF1 discriminates against binding to fully-methylated CpG-sites by steric repulsion[J]. Biophys， 2013，171(1)：38-45.

[23] Abdul-Qader A，Christian B，Marie-A1ine T，et al. ICBP90 expression is downregulated in apoptosis-induced jurkat cells[J]. Ann NY Acad Sci，2003，1010(3)：300-303.

[24] Li X，Meng Q，Rosen EM，et al. UHRFl confers radio-resistance to human breast cancer cells[J]．Int J Radiat Biol，2011，87(3)：263-273.

[25] Hoglund M，Gorunova L，Andren-Sandberg A，et al. Cytogenetand fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas： frequent loss of 19p13.3 and gain of 19q13.1-13.2[J]．Genes Chromo-somes Cancer，1998，21(1)：8-16.

[26] Sherer ME，Shekhter-Levin S，Krause JR，et al. Atypical (7∶19) translocation in acute myelomonocytic leukemia cancer genet[J]. Cytogenet，1991，57(2)：169-173.

[27] Gruber SB，Entius MM，Petersen GM，et al. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome[J]. Cancer Res， 1998，58(23)：5267-5270.

[28] Achour M，Jacq X，Ronde P，et al．The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression[J]. Oncogene，2008，27(15)：2187-2197.

[29] Michael J，Marc M，Raphael H，et al. The retinoblastoma gene and its product are targeted by ICBP90： a key mechanism in the G1/S transition during the cell cycle[J]. Oncogene， 2005，24(49)：7337-7345.

[30] Un F，Oi C，Prosser M，et al. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity[J]．Anticancer Res，2006， 26 (4B)：2761-2767.

[31] Muto M，Kanari Y，Kubo E，et al. Targeted disruption of NP95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks[J]. J Biol Chem，2002，277(37)：34549-34555.